4 research outputs found

    The g-2 of the Muon in Localized Gravity Models

    Get PDF
    The (g-2) of the muon is well known to be an important model building constraint on theories beyond the Standard Model. In this paper, we examine the contributions to (g−2)ÎŒ(g-2)_\mu arising in the Randall-Sundrum model of localized gravity for the case where the Standard Model gauge fields and fermions are both in the bulk. Using the current experimental world average measurement for (g−2)ÎŒ(g-2)_\mu, we find that strong constraints can be placed on the mass of the lightest gauge Kaluza-Klein excitation for a narrow part of the allowed range of the assumed universal 5-dimensional fermion mass parameter, Îœ\nu. However, employing both perturbativity and fine-tuning constraints we find that we can further restrict the allowed range of the parameter Îœ\nu to only one fourth of its previous size. The scenario with the SM in the RS bulk is thus tightly constrained, being viable for only a small region of the parameter space.Comment: 16 pages, 2 figs, LaTex, Additional discussion adde

    Experimental Probes of Localized Gravity: On and Off the Wall

    Get PDF
    The phenomenology of the Randall-Sundrum model of localized gravity is analyzed in detail for the two scenarios where the Standard Model (SM) gauge and matter fields are either confined to a TeV scale 3-brane or may propagate in a slice of five dimensional anti-deSitter space. In the latter instance, we derive the interactions of the graviton, gauge, and fermion Kaluza-Klein (KK) states. The resulting phenomenological signatures are shown to be highly dependent on the value of the 5-dimensional fermion mass and differ substantially from the case where the SM fields lie on the TeV-brane. In both scenarios, we examine the collider signatures for direct production of the graviton and gauge KK towers as well as their induced contributions to precision electroweak observables. These direct and indirect signatures are found to play a complementary role in the exploration of the model parameter space. In the case where the SM field content resides on the TeV-brane, we show that the LHC can probe the full parameter space and hence will either discover or exclude this model if the scale of electroweak physics on the 3-brane is less than 10 TeV. We also show that spontaneous electroweak symmetry breaking of the SM must take place on the TeV-brane.Comment: 62 pages, Latex, 22 figure

    The Effective Lagrangian in the Randall-Sundrum Model and Electroweak Physics

    Full text link
    We consider the two-brane Randall-Sundrum (RS) model with bulk gauge fields. We carefully match the bulk theory to a 4D low-energy effective Lagrangian. In addition to the four-fermion operators induced by KK exchange we find that large negative S and T parameters are induced in the effective theory. This is a tree-level effect and is a consequence of the shapes of the W and Z wave functions in the bulk. Such effects are generic in extra dimensional theories where the standard model (SM) gauge bosons have non-uniform wave functions along the extra dimension. The corrections to precision electroweak observables in the RS model are mostly dominated by S. We fit the parameters of the RS model to the experimental data and find somewhat stronger bounds than previously obtained; however, the standard model bound on the Higgs mass from precision measurements can only be slightly relaxed in this theory.Comment: 16 pages, LaTeX, 1 figure included, uses JHEP.cls, extended introduction, added reference

    Practice patterns and outcomes after stroke across countries at different economic levels (INTERSTROKE):an international observational study

    Get PDF
    Background: Stroke disproportionately affects people in low-income and middle-income countries. Although improvements in stroke care and outcomes have been reported in high-income countries, little is known about practice and outcomes in low and middle-income countries. We aimed to compare patterns of care available and their association with patient outcomes across countries at different economic levels. Methods: We studied the patterns and effect of practice variations (ie, treatments used and access to services) among participants in the INTERSTROKE study, an international observational study that enrolled 13 447 stroke patients from 142 clinical sites in 32 countries between Jan 11, 2007, and Aug 8, 2015. We supplemented patient data with a questionnaire about health-care and stroke service facilities at all participating hospitals. Using univariate and multivariate regression analyses to account for patient casemix and service clustering, we estimated the association between services available, treatments given, and patient outcomes (death or dependency) at 1 month. Findings: We obtained full information for 12 342 (92%) of 13 447 INTERSTROKE patients, from 108 hospitals in 28 countries; 2576 from 38 hospitals in ten high-income countries and 9766 from 70 hospitals in 18 low and middle-income countries. Patients in low-income and middle-income countries more often had severe strokes, intracerebral haemorrhage, poorer access to services, and used fewer investigations and treatments (p<0·0001) than those in high-income countries, although only differences in patient characteristics explained the poorer clinical outcomes in low and middle-income countries. However across all countries, irrespective of economic level, access to a stroke unit was associated with improved use of investigations and treatments, access to other rehabilitation services, and improved survival without severe dependency (odds ratio [OR] 1·29; 95% CI 1·14–1·44; all p<0·0001), which was independent of patient casemix characteristics and other measures of care. Use of acute antiplatelet treatment was associated with improved survival (1·39; 1·12–1·72) irrespective of other patient and service characteristics. Interpretation: Evidence-based treatments, diagnostics, and stroke units were less commonly available or used in low and middle-income countries. Access to stroke units and appropriate use of antiplatelet treatment were associated with improved recovery. Improved care and facilities in low-income and middle-income countries are essential to improve outcomes
    corecore